ELAZIG, TURKEY and IRVINE, CA--(Marketwired - Aug 29, 2013) - Firat University Hospital, one of the Eastern Turkey's leading health centers, and Masimo (
Firat joins a growing list of leading healthcare systems around the world using Patient SafetyNet, which can help ensure patient safety by noninvasively and continuously measuring and tracking a patient's underlying physiological conditions and detecting changes or abnormalities that signal declining health status in real-time. When changes occur in the measured values, which may indicate deterioration in the patient's condition, the system automatically sends wireless alerts directly to clinicians -- prompting a potentially lifesaving response to the patient's bedside. Patient SafetyNet also has been clinically shown to reduce preventable and costly rescue events and transfers to intensive care units.1
"We have found that Masimo Patient SafetyNet offers the best system when it comes to noninvasive bedside monitoring technologies," said Dr. Erdal Taşkin, associate professor of neonatology at Firat University Hospital. "Masimo SET® Pulse Oximetry and the Patient SafetyNet System reduced the number of clinical alarms in our neonatal intensive care unit by about 70 percent within the first five days of installation. Our workload in the NICU has been reduced because of far fewer false alarms, which we believe will help improve patient outcomes."
The installation of Patient SafetyNet at Firat University Hospital took place after an extensive evaluation process resulting in the organization's standardization to Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry. The performance of Masimo SET® pulse oximetry is proven by more than 100 independent and objective studies and thousands of clinical evaluations. Masimo SET® is trusted by clinicians to safely monitor more than 100 million patients each year and is used hospital-wide by eight of the top 10 U.S. hospitals on the U.S. News & World Report Best Hospitals Honor Roll (2013-2014). Compared to other pulse oximeters during patient motion and low perfusion, Masimo SET® provides measurements when other pulse oximeters cannot, dramatically reduces false alarms (specificity), and accurately detects true alarms (sensitivity)2,3 that can indicate a deteriorating patient. Most importantly, Masimo SET® pulse oximetry is the only technology clinically proven to improve patient outcomes by helping clinicians reduce retinopathy of prematurity (ROP)4 in neonates, screen newborns for critical congenital heart disease (CCHD),5,6 reduce ventilator weaning time and arterial blood gas measurements in the ICU,7 and save lives and costs while reducing rapid response activations and intensive care unit transfers on the general floor.3
"Firat University Hospital has earned a reputation for delivering high-quality patient care in this tremendously important region of the world," said Joe Kiani, Founder and CEO of Masimo. "Through its embrace of advanced technology and medical services, it has distinguished itself as one of the best hospitals in the area. We are happy and honored to be partners with Firat, and look forward to helping it improve patient outcomes through Masimo's advanced patient monitoring technologies."
1 Taenzer A, Blike G, McGrath S, Pyke J, Herrick M, Renaud C, Morgan J. "Postoperative Monitoring - The Dartmouth Experience." Anesthesia Patient Safety Foundation Newsletter Spring-Summer 2012. Available online.
2 Shah N, Ragaswamy HB, Govindugari K, Estanol L "Performance of Three New-Generation Pulse Oximeters during Motion and Low Perfusion in Volunteers".J Clin Anesth. 2012 Aug;24(5):385-91.
3 Taenzer, Andreas H.; Pyke, Joshua B.; McGrath, Susan P.; Blike, George T. "Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-and-After Concurrence Study." Anesthesiology, February 2010, Vol. 112, Issue 2. Available online here.
4 Castillo A, et al. Acta Paediatr. 2011 Feb.;100(2):188-92.
5 de-Wahl Granelli A., et al. BMJ. 2009 Jan 8;338.
6 Ewer A, et al. Health Technol Assess. 2012;16(2):1-184.
7 Durbin, et al. Critical Care Medicine. 2002 Aug.;30(8): 1735 to 1740.
About Firat University Hospital
Firat University Hospital is one of the Eastern Turkey's leading health centers, equipped with leading-edge technology and medical services, including a coronary intensive care unit, hemodialysis center, and a nuclear medicine unit. The hospital also is on the forefront of fertility diagnosis and treatment. Visit our website at http://ftm.firat.edu.tr
Forward Looking Statements
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions that Masimo Patient SafetyNet can help keep patients safer by noninvasively, continuously measuring and tracking their underlying physiological condition to help hospitals avoid preventable patient deaths and injuries associated with failure to rescue events, risks related to our assumptions of the repeatability of clinical results obtained, and risks related to the system's ability to significantly decrease traumatic critical events and costly ICU transfers to help improve patient outcomes and reduce costs; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57, Rad-8, Rad-5, Pulse CO-Oximetry, Pulse CO-Oximeter, Adaptive Threshold Alarm, and SEDLine are trademarks or registered trademarks of Masimo Corporation. The use of the trademarks Patient SafetyNet and PSN is under license from University HealthSystem Consortium.